
Medact member and IPPNW board member Bimal Khadka reflects on a five day, 500km ride across Kenya to attend the 2023 IPPNW World Congress in Mombasa.

Medact’s Nuclear Weapons Group represents the longest standing aspect of Medact’s work to address war, armed violence and conflict as global threats to health.

IPPNW Europe gathered together in Hamburg over 20–22 January 2023 to discuss nuclear disarmament and the prevention of nuclear war

Medact’s Nuclear Weapons Group represents the longest standing aspect of Medact’s work to address war, armed violence and conflict as global threats to health.

Medact’s Nuclear Weapons Group represents the longest standing aspect of Medact’s work to address war, armed violence and conflict as global threats to health.

Medact’s Nuclear Weapons Group represents the longest standing aspect of Medact’s work to address war, armed violence and conflict as global threats to health.

Medact’s Nuclear Weapons Group represents the longest standing aspect of Medact’s work to address war, armed violence and conflict as global threats to health.

Medact’s Nuclear Weapons Group represents the longest standing aspect of Medact’s work to address war, armed violence and conflict as global threats to health.

Medact’s Nuclear Weapons Group represents the longest standing aspect of Medact’s work to address war, armed violence and conflict as global threats to health.

Medact and Nuclear Weapons Group member Frank Boulton on last week’s 10th Nuclear Non-Proliferation Treaty Review Conference, where after two years’ delay, its states-parties failed to reach consensus on the conference’s outcomes.

Medact’s Nuclear Weapons Group will meet to reflect on activities and achievements from the 12 months, consolidate the group’s structure, and decide on the group’s campaign strategy for the next 6 months.